References
- 1. Bradley SE, Bradley GP. The effect of increased intraabdominal pressure on renal function in man. J Clin Invest. 1947;26:1010-1022.10.1172/JCI101867
- 2. Mohmand H, Goldfarb S. Renal dysfunction associated with intraabdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol. 2011;22:615-621.10.1681/ASN.2010121222
- 3. Malbrain ML, Chiumello D, Pelosi P. Prevalence of intraabdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med. 2004;30(5):822-9.10.1007/s00134-004-2169-9
- 4. Vidal MG, Ruiz Weisser J, Gonzalez F, et al. Incidence and clinical effects of intraabdominal hypertension in critically ill patients. Crit Care Med. 2008;36(6):1823-31.10.1097/CCM.0b013e31817c7a4d
- 5. Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intraabdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Medicine. 2013;399(7):1190–1206.10.1007/s00134-013-2906-z
- 6. Puiac C, Szederjesi J, Lazar A, Rad P, Almasy E, Pușcasiu L. Influence of Ventilation Parameters on Intraabdominal Pressure. The Journal of Critical Care Medicine 2016;2(2):80-8410.1515/jccm-2016-0016
- 7. Sui F, Zheng Y, Li WX. Renal circulation and microcirculation during intraabdominal hypertension in a porcine model. Eur Rev Med Pharmacol Sci. 2016;20(3):452-61
- 8. Balogh ZJ, Lumsdaine W, Moore EE. Postinjury abdominal compartment syndrome: from recognition to prevention. Lancet. 2014;384(9952):1466–147510.1016/S0140-6736(14)61689-5
- 9. Prasad D. Neutrophil gelatinase-associated lipocalin Neutrophil gelatinase-associated lipocalin (NGAL). A new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;241:89–9410.1080/00365510802150158
- 10. Garabed E, Lameire N. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter., Suppl. 2012;2:1–138
- 11. Soni SS, Bobek DC. NGAL: a biomarker of acute kidney injury and other systemic conditions. International Urology and Nephrology. 2010;42(1):141–15010.1007/s11255-009-9608-z
- 12. Laet IE, Malbrain M. Current insights in intraabdominal hypertension and abdominal compartment syndrome. Med Intensiva. 2007;31(2):88-9910.1016/S0210-5691(07)74781-2
- 13. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;241():89-9410.1080/00365510802150158252883918569973
- 14. Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest. 1995; 55(7):577-8810.3109/003655195091102578633182
- 15. Cai L, Rubin J, Han W et al. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol. 2010; 5(12):2229-35.10.2215/CJN.00980110299408420829422
- 16. Cai L, Borowiec J, Xu S, Han W, Venge P. Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances. Clin Chim Acta. 2009; 403:121.10.1016/j.cca.2009.01.03019361453
- 17. Glassford NJ, Schneider AG, Xu S, et al. The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury. Intensive Care Med. 2013;39:1714.10.1007/s00134-013-3040-723917325
- 18. Linko R, Pettila V, Kuitunen A, et al. Plasma neutrophil gelatinase-associated lipocalin and adverse outcome in critically ill patients with ventilatory support. Acta Anaesthesiol Scand. 2013;57:855.10.1111/aas.1211223556459
- 19. L. Ke, H.B. Ni, Z.H. Tong, et al. The importance of timing of decompression in severe acute pancreatitis combined with abdominal compartment syndrome. J Trauma Acute Care Surg. 2013;74:1060–106610.1097/TA.0b013e318283d92723511145
- 20. Hjortrup PB, Haase N, Wetterslev M et al. Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients. Crit Care. 2013;17(2):211.01310.1186/cc11855367252023680259
- 21. Patel ML, Sachan R, Verma A, Kamal R, Gupta KK. Neutrophil gelatinase-associated lipocalin as a biomarker of disease progression in patients with chronic kidney disease. Indian J Nephrol. 2016;26(2):125-30.10.4103/0971-4065.157799479542827051137
- 22. Munna LP, Rekha S, Misra M, Ritul K, Radhey S, Pushpalata S. Prognostic significance of urinary NGAL in chronic kidney disease. Int J NephrolRenovasc Dis. 2015;8:139–144.